selected publications
- Investigation of Strongyloides stercoralis in an intermediate care facility for developmentally disabled individuals, New York, November to December 2023. American journal of infection control. 2025 Academic Article GET IT
-
In vitro activity of taurolidine against clinical Candida auris isolates: relevance to catheter-related bloodstream infections.
Antimicrobial agents and chemotherapy.
2024
Academic Article
GET IT
Times cited: 1 -
COVID-19 vaccine effectiveness in adults with developmental disabilities living in group homes.
Public health.
2022
Letter
GET IT
Times cited: 2 -
Drive through COVID19 vaccination for developmentally disabled persons.
Vaccine.
2021
Letter
GET IT
Times cited: 2 -
Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.
2017
Academic Article
GET IT
Times cited: 11 -
DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.
Neuropharmacology.
2017
Academic Article
GET IT
Times cited: 9 - Potential for a pluripotent adult stem cell treatment for acute radiation sickness. World journal of experimental medicine. 2012 Academic Article GET IT
-
Population pharmacokinetics of oxycodone in children 6 months to 7 years old.
Journal of clinical pharmacology.
2006
Academic Article
GET IT
Times cited: 31 -
A review of the effect of occlusive dressings on lamellar bodies in the stratum corneum and relevance to transdermal absorption.
Dermatology online journal.
2005
Review
GET IT
Times cited: 11 -
Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanate.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
1999
Academic Article
GET IT
Times cited: 10 -
Penetration of ceftibuten into middle ear fluid.
Antimicrobial agents and chemotherapy.
1996
Academic Article
GET IT
Times cited: 5